Hara Maya Gurung, Eliya Shrestha, Babita Gurung, Hari Bikram Adhikari and Pawan Baral*
Himalaya Eye Hospital, Pokhara, Nepal
*Corresponding Author: Pawan Baral, Himalaya Eye Hospital, Pokhara, Nepal.
Received: July 30, 2021; Published: August 13, 2021
Purpose: Intravitreal injection Bevacizumab (IVB) has become an important tool in the armamentarium of retina specialists. Though it is considered safe, it is not completely free from causing endophthalmitis, a devastating ocular inflammation which leads to loss of vision. The purpose of this study is to find the prevalence of endophthalmitis following IVB in the operation room of Himalaya Eye Hospital (HEH).
Methods: A retrospective study of the patients who received IVB in the operation room of HEH from January 2015 to March 2021 was done. During this period, the record of the number of IVB performed and the number of patients who got endophthalmitis post IVB was taken from the database of the operation room and subsequently the details of the endophthalmitis cases were studied. Nepal Health Research Council approved this study (no 3085).
Results: A total of 3339 IVB were performed for 2105 eyes from January 2015 to March 2021. An outbreak of a single episode of cluster endophthalmitis, sterile in nature, was observed during this period which accounted to the prevalence of 0.209% of endophthalmitis following IVB in our hospital.
Conclusion: The prevalence of endophthalmitis following IVB in HEH is low. IVB which is gaining popularity in the treatment of retinal diseases, if performed with caution is safe and beneficial to the patients.
Keywords: Bevacizumab; Endophthalmitis; Prevalence; Retinal Diseases; Retina Specialists
Citation: Pawan Baral., et al. “Endophthalmitis Following Intravitreal Injection Bevacizumab in an Operation Room Setting of Nepal".Acta Scientific Ophthalmology 4.9 (2021): 17-21.
Copyright: © 2021 Pawan Baral., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.